Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accounts Payables (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Accounts Payables readings, the most recent being $970000.0 for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 21.84% to $970000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $970000.0, a 21.84% decrease, with the full-year FY2025 number at $970000.0, down 21.84% from a year prior.
  • Accounts Payables hit $970000.0 in Q4 2025 for Lucid Diagnostics, down from $2.3 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.5 million in Q1 2022 to a low of $26000.0 in Q4 2023.
  • Median Accounts Payables over the past 5 years was $1.6 million (2024), compared with a mean of $1.8 million.
  • Biggest five-year swings in Accounts Payables: crashed 97.54% in 2023 and later skyrocketed 4673.08% in 2024.
  • Lucid Diagnostics' Accounts Payables stood at $1.1 million in 2021, then fell by 5.12% to $1.1 million in 2022, then crashed by 97.54% to $26000.0 in 2023, then skyrocketed by 4673.08% to $1.2 million in 2024, then dropped by 21.84% to $970000.0 in 2025.
  • The last three reported values for Accounts Payables were $970000.0 (Q4 2025), $2.3 million (Q3 2025), and $833000.0 (Q2 2025) per Business Quant data.